Intracranial injection of siRNA BACE1-AS into AD model mice not only downregulated BACE1 protein levels but also significantly reduced insoluble Aβ production and improved learning and memory abilities in mice [55]. This evidence concerns the gene BACE1 and Alzheimer disease.